TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
| Date first appeared online | 08/02/2014 |
| DOI | 10.18632/oncotarget.1707 |
| Authors | Murray J. |
| Journal Name | Oncotarget |
| Volume | 5 |